Article · News

Health Ministry grants additional one year relief to MSME pharma companies to upgrade facilities under Schedule M

Medical Dialogues · medicaldialogues.in Free Intermediate India

The January 2025 report of the one-year extension for drug makers under Rs 250 crore turnover, and the conditions attached: a gap analysis and a compliance plan filed with the regulator.

  • Know the history: MSMEs had until 31 December 2025 and conditions to meet.
  • Do a gap analysis against revised Schedule M before buying a plant.
  • Ask any contract manufacturer for its compliance status.
Open on medicaldialogues.in ↗

The question it answers

  1. How do I start a pharma company in India?

Read with it

  1. The government's only portal for registering a micro, small or medium enterprise. It states registration is free and lists the... udyamregistration.gov.in Tool Udyam Registration (MSME) Ministry of MSME
  2. India's national drug regulator under the Drugs and Cosmetics Act 1940 and Rules 1945. It sets the rules; state licensing... cdsco.gov.in Article · Official site Central Drugs Standard Control Organisation (CDSCO) CDSCO
  3. SUGAM, the drug regulator's e-governance system for applications to CDSCO, which also links to the national drug licensing... cdscoonline.gov.in Tool · Official portal CDSCO online licensing (SUGAM and ONDLS) CDSCO
  4. December 2025 report that the revised Schedule M good manufacturing practice deadline for MSME drug makers (turnover of Rs 250... business-standard.com Article · News Health ministry unlikely to extend Schedule M GMP deadline for MSME pharma Business Standard
eChai Partner Brands The partnership →